MDR1 Polymorphisms Predict the Response to Etoposide–Cisplatin Combination Chemotherapy in Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MDR1 Polymorphisms Predict the Response to Etoposide–Cisplatin Combination Chemotherapy in Small Cell Lung Cancer

Published:2006-02-14 Issue:3 Volume:36 Page:137-141
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Sohn Ji Woong,Lee Shin Yup,Lee Su Jung,Kim Eun Jin,Cha Seung Ick,Kim Chang Ho,Lee Jae-Tae,Jung Tae Hoon,Park Jae Yong

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/36/3/137/5162166/hyi231.pdf

Reference32 articles.

1. Elias AD. Small cell lung cancer: state-of-the-art therapy in 1996. Chest1997;112:151S–58S.

2. Simon GR, Wagner H. Small cell lung cancer. Chest2003;123:259S–71S.

3. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer2002;2:48–58.

4. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell1986;47:381–9.

5. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res2001;11:1156–66.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Relapsed/Refractory Small Cell Lung Cancer Patients: Results from a Pilot Study;Cancer Management and Research;2021-08

2. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy;Journal of Experimental Pharmacology;2021-03

3. Chemotherapy Resistance Molecular Mechanism in Small Cell Lung Cancer;Current Molecular Medicine;2019-06-10

4. Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy;Frontiers in Neurology;2018-06-20

5. Chemotherapy Resistance in Lung Cancer;Lung Cancer and Personalized Medicine;2015-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3